Prinivil: Effective Blood Pressure Control for Cardiovascular Health
Prinivil
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | 1.99 $ | 59.67 $ (0%) | 🛒 Add to cart |
| 60 | 1.40 $ | 119.34 $ 84.24 $ (29%) | 🛒 Add to cart |
| 90 | 1.22 $ | 179.01 $ 109.98 $ (39%) | 🛒 Add to cart |
| 120 | 1.11 $ | 238.68 $ 133.38 $ (44%) | 🛒 Add to cart |
| 180 | 1.02 $ | 358.02 $ 183.69 $ (49%) | 🛒 Add to cart |
| 270 | 0.96 $ | 537.03 $ 259.74 $ (52%) | 🛒 Add to cart |
| 360 | 0.93 $
Best per pill | 716.04 $ 333.45 $ (53%) | 🛒 Add to cart |
| Product dosage: 2.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 120 | 0.39 $ | 46.80 $ (0%) | 🛒 Add to cart |
| 180 | 0.31 $ | 70.20 $ 56.16 $ (20%) | 🛒 Add to cart |
| 270 | 0.26 $ | 105.30 $ 69.03 $ (34%) | 🛒 Add to cart |
| 360 | 0.23 $
Best per pill | 140.40 $ 81.90 $ (42%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | 1.05 $ | 63.18 $ (0%) | 🛒 Add to cart |
| 90 | 0.90 $ | 94.77 $ 80.73 $ (15%) | 🛒 Add to cart |
| 120 | 0.83 $ | 126.36 $ 99.45 $ (21%) | 🛒 Add to cart |
| 180 | 0.74 $ | 189.54 $ 133.38 $ (30%) | 🛒 Add to cart |
| 270 | 0.70 $ | 284.31 $ 188.37 $ (34%) | 🛒 Add to cart |
| 360 | 0.67 $
Best per pill | 379.08 $ 242.19 $ (36%) | 🛒 Add to cart |
Synonyms | |||
Prinivil (lisinopril) is an angiotensin-converting enzyme (ACE) inhibitor prescribed for the management of hypertension, heart failure, and post-myocardial infarction care. It works by relaxing blood vessels, allowing blood to flow more smoothly and the heart to pump more efficiently. This medication is a cornerstone in cardiovascular therapy, trusted by clinicians for its proven efficacy and well-established safety profile. Proper use under medical supervision can significantly reduce the risk of major cardiac events and improve long-term patient outcomes.
Features
- Active ingredient: Lisinopril
- Drug class: Angiotensin-converting enzyme (ACE) inhibitor
- Available in tablet formulations: 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, 40 mg
- Typically administered once daily
- Bioavailability is approximately 25%, with peak serum concentrations occurring within 7 hours
- Excreted unchanged in the urine
- Not significantly metabolized by the liver
Benefits
- Effectively lowers high blood pressure, reducing strain on the heart and arteries
- Improves survival rates following a heart attack when initiated within 24 hours
- Slows the progression of kidney disease in hypertensive patients with diabetes
- Can be used as adjunctive therapy in the management of heart failure to improve symptoms and exercise tolerance
- Once-daily dosing supports medication adherence and consistent therapeutic levels
- Well-tolerated by most patients with a predictable side effect profile
Common use
Prinivil is primarily indicated for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents. It is also used in the management of congestive heart failure, often alongside diuretics and digitalis, to improve hemodynamics and clinical status. Additionally, Prinivil is prescribed to improve survival in hemodynamically stable patients who have experienced acute myocardial infarction. Off-label uses may include diabetic nephropathy and certain forms of chronic kidney disease, though these should only be pursued under specialist guidance.
Dosage and direction
The dosage of Prinivil must be individualized based on the patient’s clinical condition and renal function. For hypertension, the initial dose is typically 10 mg once daily, which may be increased to a maintenance dose of 20–40 mg daily. In heart failure, treatment usually begins with 2.5–5 mg once daily under close medical supervision, with gradual titration to a target maintenance dose of 20–40 mg daily. For post-myocardial infarction patients, dosing should start with 5 mg within 24 hours of the event, followed by 5 mg after 24 hours, 10 mg after 48 hours, and then 10 mg once daily. Tablets should be swallowed whole with water, with or without food, at approximately the same time each day.
Precautions
Patients should have baseline renal function and electrolyte levels assessed before initiating therapy and periodically during treatment. Prinivil may cause symptomatic hypotension, particularly in volume-depleted patients or those taking diuretics. Regular monitoring of blood pressure, serum potassium, and creatinine is essential. Angioedema may occur at any time during treatment, requiring immediate discontinuation and emergency care if involving the airway. Use with caution in patients with renal impairment, collagen vascular diseases, or those undergoing major surgery or anesthesia. Prinivil can cause fetal harm when administered to pregnant women and should be discontinued as soon as pregnancy is detected.
Contraindications
Prinivil is contraindicated in patients with a history of angioedema related to previous ACE inhibitor treatment. It should not be used in patients with hereditary or idiopathic angioedema. Concomitant use with aliskiren in patients with diabetes is contraindicated. Prinivil is also contraindicated in patients with hypersensitivity to any component of this product or other ACE inhibitors. The medication is contraindicated during the second and third trimesters of pregnancy due to the risk of fetal injury and death.
Possible side effect
Common adverse reactions include dizziness (6–12%), headache (5–6%), cough (3–9%), fatigue (3–5%), and nausea (2–4%). Less frequently, patients may experience orthostatic hypotension, rash, impotence, and taste disturbance. Serious side effects requiring medical attention include angioedema (0.1–0.5%), hyperkalemia, renal impairment, neutropenia/agranulocytosis, and hepatic failure. The incidence of cough is higher in women and non-smokers. Most side effects are dose-dependent and may diminish with continued therapy or dose reduction.
Drug interaction
Prinivil may interact with several medications, including diuretics (increased risk of hypotension), potassium-sparing diuretics or potassium supplements (increased risk of hyperkalemia), lithium (increased lithium levels), nonsteroidal anti-inflammatory drugs (NSAIDs) (diminished antihypertensive effect and risk of renal impairment), and antidiabetic agents (increased risk of hypoglycemia). Concurrent use with other antihypertensive agents may result in additive hypotensive effects. Alcohol may potentiate the blood pressure-lowering effects of Prinivil.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is nearly time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should not take a double dose to make up for a missed one. Consistent daily administration is important for maintaining stable blood pressure control, so patients should establish routines to support adherence.
Overdose
Symptoms of overdose may include severe hypotension, bradycardia, circulatory shock, hyperkalemia, renal failure, and electrolyte imbalances. Management involves supportive care, including volume expansion with normal saline to treat hypotension. Lisinopril can be removed from the body by hemodialysis. Patients suspected of overdose should receive immediate medical attention, with continuous monitoring of vital signs, electrolyte levels, and renal function.
Storage
Prinivil tablets should be stored at controlled room temperature (20–25°C or 68–77°F) in their original container, protected from light and moisture. Keep the medication out of reach of children and pets. Do not use tablets beyond the expiration date printed on the packaging. Proper disposal of unused medication should follow local regulations, typically through medication take-back programs rather than flushing or household trash.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Prinivil is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Patients should not initiate, discontinue, or modify their dosage without consulting their physician. Individual responses to medication may vary, and this information may not include all possible uses, directions, precautions, or interactions.
Reviews
Clinical studies demonstrate that Prinivil effectively reduces blood pressure in 70–80% of patients with mild to moderate hypertension. In the GISSI-3 trial, lisinopril significantly reduced mortality when started early after myocardial infarction. The SOLVD treatment trial showed that lisinopril reduced mortality and hospitalization in patients with heart failure. Patient satisfaction surveys indicate good tolerability, though the persistent cough leads to discontinuation in approximately 5–10% of users. Many clinicians appreciate its once-daily dosing and proven cardiovascular benefits.